Sarepta (SRPT) PT Lowered to $23 at Baird as FDA Digs in for a Fight on Eteplirsen
Go back to Sarepta (SRPT) PT Lowered to $23 at Baird as FDA Digs in for a Fight on Eteplirsen| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.78 +0.25 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.53 | 52 Week High | $63.73 | |||
| Open | $17.82 | 52 Week Low | $8.00 | |||
| Day High | $18.00 | P/E | N/A | |||
| Day Low | $17.50 | EPS | $-5.69 | |||
| Volume | 221,277 | |||||
